DATASHEET
Host:
Rabbit
Target Protein:
PLAG1
Immunogen Range:
20-70/500
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
5324
Swiss Prot:
Q6DJT9
Source:
KLH conjugated synthetic peptide derived from human PLAG1
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Store at -20°C for 12 months.
Background:
Transcription factor whose activation results in up-regulation of target genes, such as IGFII, leading to uncontrolled cell proliferation: when overexpressed in cultured cells, higher proliferation rate and transformation are observed. Other target genes such as CRLF1, CRABP2, CRIP2, PIGF are strongly induced in cells with PLAG1 induction. Proto-oncogene whose ectopic expression can trigger the development of pleomorphic adenomas of the salivary gland and lipoblastomas. Overexpression is associated with up-regulation of IGFII, is frequently observed in hepatoblastoma, common primary liver tumor in childhood. Cooperates with CBFB-MYH11, a fusion gene important for myeloid leukemia.
VALIDATION IMAGES
Lane 1: Human 293T cell Lysates; Lane 2: Human HUVEC cell Lysates; Lane 3: Human Hela cell Lysates; Lane 4: Human Jurkat cell Lysates; Lane 5: Human U2OS cell Lysates. Probed with PLAG1 polyclonal Antibody, unconjugated (bs-5969R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Human Huvec cell lysates; Lane 2: Human Hela cell lysates; Lane 3: Human Jurkat cell lysates; Lane 4: Human U2OS cell lysates probed with PLAG1 Polyclonal Antibody, Unconjugated (bs-5969R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.